ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.72 Million USD | -3.72% |
| 2022 | 11.14 Million USD | -79.46% |
| 2021 | 54.25 Million USD | 46.4% |
| 2020 | 37.06 Million USD | -6.54% |
| 2019 | 39.65 Million USD | -14.3% |
| 2018 | 46.27 Million USD | -47.84% |
| 2017 | 88.7 Million USD | 1159.84% |
| 2016 | 7.04 Million USD | -39.23% |
| 2015 | 11.58 Million USD | -19.46% |
| 2014 | 14.38 Million USD | -45.48% |
| 2013 | 26.38 Million USD | 1.12% |
| 2012 | 26.09 Million USD | -19.67% |
| 2011 | 32.48 Million USD | -16.03% |
| 2010 | 38.68 Million USD | 138.6% |
| 2009 | 16.21 Million USD | -42.66% |
| 2008 | 28.27 Million USD | -52.11% |
| 2007 | 59.05 Million USD | 63.74% |
| 2006 | 36.06 Million USD | 211.95% |
| 2005 | 11.56 Million USD | 0.0% |
| 2003 | 717 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.23 Million USD | -23.27% |
| 2024 Q2 | 6.39 Million USD | -22.33% |
| 2023 Q1 | 16.35 Million USD | 46.76% |
| 2023 FY | 10.72 Million USD | -3.72% |
| 2023 Q4 | 10.72 Million USD | 37.05% |
| 2023 Q3 | 7.82 Million USD | -33.96% |
| 2023 Q2 | 11.85 Million USD | -27.52% |
| 2022 Q4 | 11.14 Million USD | -60.84% |
| 2022 Q2 | 41.92 Million USD | -11.31% |
| 2022 Q1 | 47.27 Million USD | -12.88% |
| 2022 FY | 11.14 Million USD | -79.46% |
| 2022 Q3 | 28.45 Million USD | -32.13% |
| 2021 Q1 | 36.01 Million USD | -2.82% |
| 2021 FY | 54.25 Million USD | 46.4% |
| 2021 Q3 | 90.69 Million USD | -24.42% |
| 2021 Q2 | 120 Million USD | 233.19% |
| 2021 Q4 | 54.25 Million USD | -40.18% |
| 2020 Q2 | 37.14 Million USD | -1.1% |
| 2020 FY | 37.06 Million USD | -6.54% |
| 2020 Q1 | 37.55 Million USD | -5.29% |
| 2020 Q4 | 37.06 Million USD | 1.28% |
| 2020 Q3 | 36.59 Million USD | -1.49% |
| 2019 Q3 | 44.18 Million USD | 1.13% |
| 2019 FY | 39.65 Million USD | -14.3% |
| 2019 Q4 | 39.65 Million USD | -10.25% |
| 2019 Q1 | 47.42 Million USD | 2.49% |
| 2019 Q2 | 43.69 Million USD | -7.87% |
| 2018 Q3 | 47.05 Million USD | -6.85% |
| 2018 Q1 | 78.56 Million USD | -11.43% |
| 2018 FY | 46.27 Million USD | -47.84% |
| 2018 Q4 | 46.27 Million USD | -1.66% |
| 2018 Q2 | 50.51 Million USD | -35.71% |
| 2017 Q1 | 21.7 Million USD | 208.33% |
| 2017 FY | 88.7 Million USD | 1159.84% |
| 2017 Q4 | 88.7 Million USD | 60.75% |
| 2017 Q3 | 55.18 Million USD | 29.78% |
| 2017 Q2 | 42.52 Million USD | 95.86% |
| 2016 Q3 | 10.57 Million USD | -29.44% |
| 2016 Q4 | 7.04 Million USD | -33.42% |
| 2016 FY | 7.04 Million USD | -39.23% |
| 2016 Q2 | 14.98 Million USD | 0.9% |
| 2016 Q1 | 14.85 Million USD | 28.2% |
| 2015 Q4 | 11.58 Million USD | -22.81% |
| 2015 FY | 11.58 Million USD | -19.46% |
| 2015 Q1 | 14.33 Million USD | -0.35% |
| 2015 Q3 | 15.01 Million USD | 90.38% |
| 2015 Q2 | 7.88 Million USD | -45.0% |
| 2014 Q4 | 14.38 Million USD | -23.83% |
| 2014 FY | 14.38 Million USD | -45.48% |
| 2014 Q3 | 18.88 Million USD | -22.63% |
| 2014 Q2 | 24.4 Million USD | -11.4% |
| 2014 Q1 | 27.55 Million USD | 4.41% |
| 2013 Q2 | 26.88 Million USD | -19.09% |
| 2013 Q1 | 33.22 Million USD | 27.31% |
| 2013 Q4 | 26.38 Million USD | 6.99% |
| 2013 FY | 26.38 Million USD | 1.12% |
| 2013 Q3 | 24.66 Million USD | -8.25% |
| 2012 Q2 | 30.52 Million USD | 24.32% |
| 2012 Q4 | 26.09 Million USD | -15.06% |
| 2012 FY | 26.09 Million USD | -19.67% |
| 2012 Q1 | 24.55 Million USD | -24.42% |
| 2012 Q3 | 30.72 Million USD | 0.65% |
| 2011 Q4 | 32.48 Million USD | -12.2% |
| 2011 Q2 | 29.06 Million USD | -13.68% |
| 2011 Q3 | 36.99 Million USD | 27.28% |
| 2011 FY | 32.48 Million USD | -16.03% |
| 2011 Q1 | 33.67 Million USD | -12.95% |
| 2010 Q2 | 11.77 Million USD | -27.26% |
| 2010 Q4 | 38.68 Million USD | 162.41% |
| 2010 Q1 | 16.18 Million USD | -0.21% |
| 2010 FY | 38.68 Million USD | 138.6% |
| 2010 Q3 | 14.74 Million USD | 25.26% |
| 2009 FY | 16.21 Million USD | -42.66% |
| 2009 Q2 | 36.61 Million USD | -1.51% |
| 2009 Q4 | 16.21 Million USD | -43.38% |
| 2009 Q3 | 28.63 Million USD | -21.79% |
| 2009 Q1 | 37.18 Million USD | 31.48% |
| 2008 Q2 | 40.39 Million USD | -19.36% |
| 2008 Q4 | 28.27 Million USD | -6.76% |
| 2008 Q3 | 30.32 Million USD | -24.92% |
| 2008 FY | 28.27 Million USD | -52.11% |
| 2008 Q1 | 50.08 Million USD | -15.18% |
| 2007 FY | 59.05 Million USD | 63.74% |
| 2007 Q4 | 59.05 Million USD | 139.48% |
| 2007 Q3 | 24.65 Million USD | 0.0% |
| 2006 Q4 | 36.06 Million USD | 0.0% |
| 2006 FY | 36.06 Million USD | 211.95% |
| 2005 FY | 11.56 Million USD | 0.0% |
| 2005 Q4 | 11.56 Million USD | 0.0% |
| 2003 FY | 717 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 65.801% |
| BrainsWay Ltd. | 62.97 Million USD | 82.965% |
| Cerus Corporation | 197.74 Million USD | 94.575% |
| Envoy Medical, Inc. | 7.64 Million USD | -40.406% |
| electroCore, Inc. | 16.38 Million USD | 34.54% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -39.457% |
| IceCure Medical Ltd | 16.41 Million USD | 34.631% |
| Inogen, Inc. | 326.19 Million USD | 96.711% |
| OrthoPediatrics Corp. | 449.58 Million USD | 97.614% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 60.664% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 35.298% |
| MaxCyte, Inc. | 268.27 Million USD | 96.001% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -32.476% |
| Nexalin Technology, Inc. | 3.63 Million USD | -195.354% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.841% |
| PAVmed Inc | 33.11 Million USD | 67.611% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 92.522% |
| RxSight, Inc. | 182.55 Million USD | 94.124% |
| Sight Sciences, Inc. | 166.65 Million USD | 93.563% |
| SI-BONE, Inc. | 230.42 Million USD | 95.345% |
| TELA Bio, Inc. | 78.04 Million USD | 86.256% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 95.742% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 0.028% |
| Acutus Medical, Inc. | 53.96 Million USD | 80.12% |
| Talis Biomedical Corporation | 98.34 Million USD | 89.092% |
| Spectral AI, Inc. | 10.69 Million USD | -0.327% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 95.094% |
| CVRx, Inc. | 115.22 Million USD | 90.691% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 81.714% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -244.338% |
| Bioventus Inc. | 810.91 Million USD | 98.677% |
| Venus Concept Inc. | 93.65 Million USD | 88.546% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 58.301% |
| LivaNova PLC | 2.42 Billion USD | 99.558% |
| 908 Devices Inc. | 202.98 Million USD | 94.715% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.668% |
| Nemaura Medical Inc. | 14.56 Million USD | 26.342% |
| NeuroPace, Inc. | 107.65 Million USD | 90.035% |
| LENSAR, Inc. | 69.58 Million USD | 84.584% |
| Apyx Medical Corporation | 79.24 Million USD | 86.463% |
| Cutera, Inc. | 346.29 Million USD | 96.902% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 74.469% |
| BioSig Technologies, Inc. | 1.79 Million USD | -496.607% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 96.036% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 74.855% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.716% |
| Axonics, Inc. | 719.92 Million USD | 98.51% |
| Outset Medical, Inc. | 313.8 Million USD | 96.582% |
| IRIDEX Corporation | 34.43 Million USD | 68.849% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.35% |
| IRadimed Corporation | 92.15 Million USD | 88.36% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -104.168% |
| INVO Bioscience, Inc. | 20.88 Million USD | 48.645% |
| Telesis Bio, Inc. | 70.41 Million USD | 84.765% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 93.039% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.142% |
| Quipt Home Medical Corp. | 247.4 Million USD | 95.664% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -15.22% |
| Pulmonx Corporation | 178.95 Million USD | 94.006% |
| Dynatronics Corporation | 25.94 Million USD | 58.648% |
| Modular Medical, Inc. | 13.8 Million USD | 22.308% |
| Semler Scientific, Inc. | 78.06 Million USD | 86.259% |
| InMode Ltd. | 863.28 Million USD | 98.757% |
| Bruker Corporation | 4.24 Billion USD | 99.748% |
| Cytosorbents Corporation | 53.26 Million USD | 79.859% |
| DexCom, Inc. | 6.26 Billion USD | 99.829% |
| Align Technology, Inc. | 6.08 Billion USD | 99.824% |
| Viveve Medical, Inc. | 25.91 Million USD | 58.604% |
| ZimVie Inc. | 1.2 Billion USD | 99.11% |
| Movano Inc. | 9.42 Million USD | -13.863% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 97.845% |
| Nexalin Technology, Inc. | 3.63 Million USD | -195.354% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 81.714% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.874% |
| Profound Medical Corp. | 43.68 Million USD | 75.445% |
| Insulet Corporation | 2.58 Billion USD | 99.586% |
| enVVeno Medical Corporation | 48.63 Million USD | 77.944% |
| Surmodics, Inc. | 185.73 Million USD | 94.225% |
| iCAD, Inc. | 41.41 Million USD | 74.101% |
| Nuwellis, Inc. | 9.77 Million USD | -9.795% |
| Biotricity, Inc. | 5.94 Million USD | -80.509% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 97.523% |
| Aethlon Medical, Inc. | 8.24 Million USD | -30.088% |
| InspireMD, Inc. | 47.64 Million USD | 77.485% |
| PAVmed Inc. | 33.11 Million USD | 67.611% |
| BIOLASE, Inc. | 35.1 Million USD | 69.44% |
| Beyond Air, Inc. | 56.96 Million USD | 81.168% |
| FONAR Corporation | 214.24 Million USD | 94.993% |
| AxoGen, Inc. | 196.82 Million USD | 94.55% |
| Vivani Medical, Inc. | 45.79 Million USD | 76.577% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 96.189% |
| Inari Medical, Inc. | 674.23 Million USD | 98.409% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.346% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 54.155% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -12.879% |
| Tenon Medical, Inc. | 6.34 Million USD | -69.062% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -14.032% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 89.651% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.768% |
| Sintx Technologies, Inc. | 15.36 Million USD | 30.185% |
| NanoVibronix, Inc. | 6.67 Million USD | -60.728% |
| Quanterix Corporation | 425.01 Million USD | 97.476% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -15.22% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 80.034% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.386% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.481% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 83.025% |
| NeuroMetrix, Inc. | 21.42 Million USD | 49.931% |
| Hyperfine, Inc. | 94.19 Million USD | 88.612% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.007% |
| Biomerica, Inc. | 9.25 Million USD | -15.917% |
| Bone Biologics Corporation | 3.73 Million USD | -186.99% |
| AVITA Medical, Inc. | 144.33 Million USD | 92.568% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -120.333% |
| Silk Road Medical, Inc | 265.3 Million USD | 95.957% |